MECOM and ovarian carcinoma: Our results were consistent with the previously reported EVI1 ChIP-Seq study in ovarian cancer cells which reported 5097 EVI1 significant binding peaks with an ETS-like motif, and over 2000 direct gene targets bound by EVI1 through the ETS-like motif [28].